Live Breaking News & Updates on Medical Technology Platforms

Stay updated with breaking news from Medical technology platforms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Responding to challenge of COVID-19

The arrival of COVID-19 in Japan in early 2020 prompted a concerted research effort at RIKEN. A strong research capacity in immunology, molecular biology. ....

Tomohiro Morio , Kazuo Kitaura , Rikiya Watanabe , Shigeo Koyasu , Keio University School Of Medicine , Japanese Society For Immunology , Molecular Physiology Laboratory , Program For Drug Discovery , Technology Platforms , Integrative Medical Sciences , International Union Of Immunological Societies , Molecular Biology Society Of Japan , Harvard University , University Of Tokyo , Vaccine Innovation Laboratory , Federation Of Immunological Societies Asia , Drug Discovery , Medical Technology Platforms , Physiology Laboratory , Middle East , Ken Ichi Masuda , Innovation Laboratory , Tokyo Medical , Dental University , Executive Director , Keio University School ,

Responding to the challenge of COVID-19

Responding to the challenge of COVID-19
riken.jp - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from riken.jp Daily Mail and Mail on Sunday newspapers.

Kazuo Kitaura , Technology Platforms , Program For Drug Discovery , Drug Discovery , Medical Technology Platforms , காஸூவொ கிட்ட Aura ரா , தொழில்நுட்பம் தளங்கள் , ப்ரோக்ர்யாம் க்கு மருந்து கண்டுபிடிப்பு , மருந்து கண்டுபிடிப்பு , மருத்துவ தொழில்நுட்பம் தளங்கள் ,

Novo Integrated Sciences Effects Reverse Stock Split in Connection with Nasdaq Capital Market Listing Application

Novo Integrated Sciences Effects Reverse Stock Split in Connection with Nasdaq Capital Market Listing Application
Novo Integrated Sciences Effects Reverse Stock Split in Connection with Nasdaq Capital Market Listing Application
Novo Integrated Sciences, Inc. (OTCQB:NVOS) (OTCQB:NVOSD), a provider of multi-dimensional primary healthcare services and products in Canada and the U.S. (the Company”), announced today it has effected a 1-for-10 reverse split of its common stock effective prior to the opening of the market today, Monday, February 1, 2021. Beginning today, the Companys common stock will trade on a post-split basis under the symbol NVOSD. After 20 business days, the common stock will return to trading under the symbol NVOS. As a result of the reverse stock split, the CUSIP number for the Companys common stock has changed. The new CUSIP number for the Companys common stock is 67011T 201. ....

Chris David , Exchange Commission , Technology Platforms , Novo Integrated Sciences , Securities Exchange , Novo Integrated Sciences Inc , Novo Healthnet Limited , Nasdaq Capital Market , Companys Board , Integrated Sciences , Medical Technology Platforms , Securities Act , Securities Exchange Act , Novo Integrated Science , கிறிஸ் டேவிட் , பரிமாற்றம் தரகு , தொழில்நுட்பம் தளங்கள் , நோவோ ஒருங்கிணைந்த அறிவியல் , பத்திரங்கள் பரிமாற்றம் , நோவோ ஒருங்கிணைந்த அறிவியல் இன்க் , நோவோ ஹெல்த்நெட் வரையறுக்கப்பட்டவை , நாஸ்டாக் மூலதனம் சந்தை , தோழர்கள் பலகை , ஒருங்கிணைந்த அறிவியல் , மருத்துவ தொழில்நுட்பம் தளங்கள் , பத்திரங்கள் நாடகம் ,